Amicrobe
Carlsbad, US · Delaware corporation
Founders & leadership
AC
Albert CarnesaleNamed on SEC filing
MB
Michael BevilacquaNamed on SEC filing
MF
Michael FleschNamed on SEC filing
MB
Martin BurnsNamed on SEC filing
DH
Daniel HuangNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$21.7M disclosed across 2 rounds · 2013–2020
▶$16.7MraisedApr 2024 · 32 investors · BiotechnologyRule 506(b)
▶$16.7MraisedApr 2024 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Albert CarnesaleDirector
- Michael BevilacquaExecutive Officer, Director
- Michael FleschExecutive Officer, Director
- Martin BurnsDirector
- Daniel HuangExecutive Officer
- Offering amount
- $24.6M
- Amount sold
- $16.7M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedApr 2024 · 51 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2024 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin BurnsDirector
- Albert CarnesaleDirector
- Daniel HuangExecutive Officer
- Michael BevilacquaExecutive Officer, Director
- Michael FleschExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Amicrobe raised?
- Amicrobe has disclosed $21.7M raised across 2 rounds.
- Where is Amicrobe headquartered?
- Amicrobe is headquartered in Carlsbad, US.